DURHAM, N.C. -- Rewarding hospitals by paying them for performance may be ill-spent money, researchers here found, citing no significant difference in acute MI outcomes between hospitals in a Medicare incentive program and those that were not.

CHICAGO -- An updated and expanded meta-analysis has reinforced the survival advantage conferred by adjuvant chemotherapy in non-small-cell lung cancer, first hinted at 12 years ago.

HANOVER, N.H. -- Folic acid supplements did not decrease the risk of new large-intestine adenomas, researchers here reported.

NASHVILLE -- Researchers here say they've found a way to tell which lung cancer patients will benefit from new targeted -- and expensive --therapies.

CHICAGO -- Pemetrexed (Alimta) plus platinum chemotherapy for advanced non-small cell lung cancer (NSCLC) may reduce toxicity compared with a gemcitabine (Gemzar) and platinum doublet but hold little other advantage.

CHICAGO -- A shorter lead-in time between recommended vitamin B12 supplementation and pemetrexed (Alimta) therapy may reduce treatment delays without impairing its efficacy.

PHILADELPHIA -- Magnets and batteries may cause serious harm if swallowed, necessitating endoscopic or surgical removal.

PHILADELPHIA -- An average of 15 in-flight medical emergencies happen on domestic flights every day in the United States, according to estimates from the Federal Aviation Administration (FAA).

SAN DIEGO -- Men older than 50 with androgen deficiency are at a greater risk for all-cause mortality than their peers with age-appropriate testosterone, reported investigators here.

CHICAGO, June 5 -- Targeted therapy missed the mark as maintenance therapy for small-cell lung cancer, researchers reported here.

CHICAGO -- Cetuximab (Erbitux) added to first-line chemotherapy for metastatic colorectal cancer lengthens progression-free survival by about a month, researchers found.

CHICAGO -- Recurrence rates for resectable liver metastases from colorectal cancer are lower when adjuvant and neoadjuvant chemotherapy augment surgery, researchers said here.

CHICAGO -- Parents of children with cancer gain hope from information about the prognosis, even when the outlook is poor, according to a survey.

CHICAGO -- For infants and children with intermediate-risk neuroblastoma, a milder therapy regimen can preserve good long-term survival and minimize toxicity, found an international trial.

CHICAGO -- Arsenic trioxide (Trisenox) improves survival for acute promyelocytic leukemia when added to first-line treatment, researchers found.

CHICAGO -- Radium-223, an investigational bone-seeking radioisotope, appeared to slow progression of skeletal metastases in hormone-refractory prostate cancer, researchers reported here.

KINGSTON, Ontario -- Using antipsychotic drugs to treat patients with dementia may be fatal, according to researchers here.

ROCHESTER, N.Y. -- Surgery for intractable temporal lobe epilepsy may cause a decline in verbal recall memory in about a third of patients, but the opportunity to end seizures may be worth the risk, investigators here said.

CHICAGO -- Oxaliplatin (Eloxatin)-containing chemotherapy boosts overall survival for stage III colon cancer, with a hint of benefit for high-risk stage II disease as well, according to large randomized trial.

BOSTON -- Suicidal tendencies that arise in some men who start on the antidepressant citalopram (Celexa) may be linked to genetic mutations, investigators in Boston and Dallas reported.